Elekta -> Falling Wedge / Divergence / Support- Falling Wedge Formation
- Great Divergence at 1D & 4H timeframe
- Massive support area
- Good Risk / Reward
ZOOM OUT TO SEE THE SUPPORT FROM WEEKS BACK UNTIL NOW
0.330EUR
83.13 MEUR
1.49 BEUR
359.71 M
About ELEKTA AB B SK 2
Sector
Industry
CEO
Gustaf Salford
Website
Headquarters
Stockholm
Employees (FY)
4.39 K
Founded
1972
ISIN
SE0000163628
FIGI
BBG003FDBY83
Elekta AB is a medical technology company, which engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: North and South America, Europe, Middle East and Africa and Asia Pacific. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ELEKTA AB B SK 2 stocks are traded under the ticker EJXB.
ELEKTA AB B SK 2 is going to release the next earnings report on Jun 5, 2024. Keep track of upcoming events with our Earnings Calendar.
EJXB earnings for the last quarter are 0.08 EUR per share, whereas the estimation was 0.07 EUR resulting in a 8.47% surprise. The estimated earnings for the next quarter are 0.09 EUR per share. See more details about ELEKTA AB B SK 2 earnings.
ELEKTA AB B SK 2 revenue for the last quarter amounts to 398.78 M EUR despite the estimated figure of 383.73 M EUR. In the next quarter revenue is expected to reach 407.81 M EUR.
Yes, you can track ELEKTA AB B SK 2 financials in yearly and quarterly reports right on TradingView.
EJXB net income for the last quarter is 27.10 M EUR, while the quarter before that showed 28.99 M EUR of net income which accounts for −6.51% change. Track more ELEKTA AB B SK 2 financial stats to get the full picture.
ELEKTA AB B SK 2 dividend yield was 2.79% in 2022, and payout ratio reached 97.24%. The year before the numbers were 3.60% and 79.46% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, EJXB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ELEKTA AB B SK 2 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 4.39 K employees. See our rating of the largest employees — is ELEKTA AB B SK 2 on this list?
We've gathered analysts' opinions on ELEKTA AB B SK 2 future price: according to them, EJXB price has a max estimate of 9.74 EUR and a min estimate of 5.74 EUR. Read a more detailed ELEKTA AB B SK 2 forecast: see what analysts think of ELEKTA AB B SK 2 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ELEKTA AB B SK 2 EBITDA is 286.42 M EUR, and current EBITDA margin is 17.74%. See more stats in ELEKTA AB B SK 2 financial statements.